Caruso A - Search Results

1

Ocular Half-Life of Intravitreal Biologics in Humans and Other Species: Meta-Analysis and Model-Based Prediction.

Caruso A, Füth M, Alvarez-Sánchez R, Belli S, Diack C, Maass KF, Schwab D, Kettenberger H, Mazer NA. Caruso A, et al. Mol Pharm. 2020 Feb 3;17(2):695-709. doi: 10.1021/acs.molpharmaceut.9b01191. Epub 2020 Jan 16. Mol Pharm. 2020. PMID: 31876425

2

PK/PD assessment in CNS drug discovery: Prediction of CSF concentration in rodents for P-glycoprotein substrates and application to in vivo potency estimation.

Caruso A, Alvarez-Sánchez R, Hillebrecht A, Poirier A, Schuler F, Lavé T, Funk C, Belli S. Caruso A, et al. Biochem Pharmacol. 2013 Jun 1;85(11):1684-99. doi: 10.1016/j.bcp.2013.02.021. Epub 2013 Feb 27. Biochem Pharmacol. 2013. PMID: 23454189

3

Theoretical Insights into the Retinal Dynamics of Vascular Endothelial Growth Factor in Patients Treated with Ranibizumab, Based on an Ocular Pharmacokinetic/Pharmacodynamic Model.

Hutton-Smith LA, Gaffney EA, Byrne HM, Caruso A, Maini PK, Mazer NA. Hutton-Smith LA, et al. Among authors: caruso a. Mol Pharm. 2018 Jul 2;15(7):2770-2784. doi: 10.1021/acs.molpharmaceut.8b00280. Epub 2018 May 29. Mol Pharm. 2018. PMID: 29734810

4

Correspondence.

Caruso A, Mazer NA. Caruso A, et al. Retina. 2020 Apr;40(4):e13. doi: 10.1097/IAE.0000000000002710. Retina. 2020. PMID: 31834136 Free PMC article. No abstract available.

5

Does the Fc Region Have a Role in the Ocular Half-life After Intravitreal Injection?

Caruso A, Mazer NA. Caruso A, et al. Invest Ophthalmol Vis Sci. 2020 May 11;61(5):20. doi: 10.1167/iovs.61.5.20. Invest Ophthalmol Vis Sci. 2020. PMID: 32407522 Free PMC article. No abstract available.

6

Understanding the Half-Life Extension of Intravitreally Administered Antibodies Binding to Ocular Albumin.

Hauri S, Jakubiak P, Fueth M, Dengl S, Belli S, Alvarez-Sánchez R, Caruso A. Hauri S, et al. Among authors: caruso a. Pharmaceutics. 2020 Aug 26;12(9):810. doi: 10.3390/pharmaceutics12090810. Pharmaceutics. 2020. PMID: 32858986 Free PMC article.

7

Ocular Pharmacokinetics of Intravitreally Injected Protein Therapeutics: Comparison among Standard-of-Care Formats.

Jakubiak P, Alvarez-Sánchez R, Fueth M, Broders O, Kettenberger H, Stubenrauch K, Caruso A. Jakubiak P, et al. Among authors: caruso a. Mol Pharm. 2021 Jun 7;18(6):2208-2217. doi: 10.1021/acs.molpharmaceut.0c01218. Epub 2021 May 20. Mol Pharm. 2021. PMID: 34014104

8

International consortium for innovation and quality: An industry perspective on the nonclinical and early clinical development of intravitreal drugs.

Pruimboom-Brees IM, Gupta S, Chemuturi N, Booler HS, Nimz E, Ferrell Ramos M, Caruso A, Maass KF, Bantseev V, Huang Q, Choules MP, Nussbaum JC, Kanodia J, Thompson C, Durairaj C. Pruimboom-Brees IM, et al. Among authors: caruso a. Clin Transl Sci. 2023 May;16(5):723-741. doi: 10.1111/cts.13480. Epub 2023 Feb 2. Clin Transl Sci. 2023. PMID: 36651217 Free PMC article.

9

Are Ocular and Serum Half-Lives After Ranibizumab Intravitreal Injection Dependent on Dose?

van Donge T, Brizzi F, Caruso A, Fueth M, Steiert B. van Donge T, et al. Among authors: caruso a. Transl Vis Sci Technol. 2023 Apr 3;12(4):9. doi: 10.1167/tvst.12.4.9. Transl Vis Sci Technol. 2023. PMID: 37040126 Free PMC article. No abstract available.

10

Translational PK/PD modeling for cardiovascular safety assessment of drug candidates: Methods and examples in drug development.

Caruso A, Frances N, Meille C, Greiter-Wilke A, Hillebrecht A, Lavé T. Caruso A, et al. J Pharmacol Toxicol Methods. 2014 Jul-Aug;70(1):73-85. doi: 10.1016/j.vascn.2014.05.004. Epub 2014 May 28. J Pharmacol Toxicol Methods. 2014. PMID: 24879942

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,315 results

Search Page